Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women Under the Age of 50 Years
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-019-1143-y
Full Text
Open PDFAbstract
Available in full text
Date
May 6, 2019
Authors
Publisher
Springer Science and Business Media LLC